Mucin 5AC (MUC5AC) is one of the main airway mucins implicated in pulmonary diseases with mucous hypersecretion. Neutrophil elastase (NE), a serine protease released by neutrophils, is known to induce MUC5AC synthesis by increasing reactive oxygen species (ROS) generation. Nuclear factor erythroid-2 related factor 2 (Nrf2), a basic-region leucine-zipper transcription factor, is believed to protect against ROS damage by activating a series of antioxidant enzymes; Nrf2 is also reported to reduce NE activity. The aim of our study was to examine the relationship between Nrf2 expression and NE-induced MUC5AC production. We used a small interfering RNA to inhibit Nrf2 expression. The Nrf2 gene and protein expressions were assessed by quantitative real-time polymerase chain reaction, and Western blotting, respectively. The ROS generation was examined using a kit. The expression of MUC5AC was assessed using enzyme-linked immunosorbent assay. The results showed that NCI-H292 epithelial cells, in which the Nrf2 gene expression repressed, were highly predisposed to NE stimulation, with marked exacerbation of ROS generation and reduced secretory leukocyte protease inhibitor production, resulting in high MUC5AC expression. Pretreatment with the potent Nrf2 activator sulforaphane had the reverse effect. These results demonstrate that Nrf2 is a novel nuclear factor involved in down-regulating MUC5AC synthesis by inhibiting ROS generation and augmenting proteinase inhibitor production.
KooJS, KimYD, JettenAM, . Overexpression of mucin genes induced by interleukin-1 beta, tumor necrosis factor-alpha, lipopolysaccharide, and neutrophil elastase is inhibited by a retinoic acid receptor alpha antagonist. Exp Lung Res. 2002;28:315–332.
4.
FischerB, VoynowJ. Neutrophil elastase induces MUC5AC messenger RNA expression by an oxidant-dependent mechanism. Chest. 2000;117:317S–320S.
5.
McCubreyJA, LahairMM, FranklinRA. Reactive oxygen species-induced activation of the MAPK kinase signaling. Antioxid Redox Signal. 2006;8:1775–1789.
6.
NadelJA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res. 2001;2:85–89.
7.
KohriK, UekiIF, NadelJA. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol. 2002;283:L531–L540.
8.
BurgelPR, NadelJA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax. 2004;59:992–996.
9.
KuwaharaI, LillehojEP, KogaT, . The signaling pathway involved in neutrophil elastase stimulated MUC1 transcription. Am J Respir Cell Mol Biol. 2007;37:691–698.
10.
AzadN, RojanasakulY, VallyathanV. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 2008;11:1–15.
11.
DongCC, YinXJ, MaJY, . Effects of diesel exhaust particles on allergic reactions and airway responsiveness in ovalbumin-sensitized brown Norway rats. Toxicol Sci. 2005;88:202–212.
12.
FubiniB, HubbardA. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med. 2003;34:1507–1516.
13.
AfonsoV, ChampyR, MitrovicD, . Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine. 2007;74:324–329.
14.
IshiiT, ItohK, TakahashiS, . Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem. 2000;275:16023–16029.
15.
ChoiAMK, AlamJ.Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996;15:9–19.
16.
RyterSW, ChoiAM. Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal. 2005;7:80–91.
17.
MainesMD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–547.
18.
LeeJM, LiJ, JohnsonDA, . Nrf2, a multi-organ protector?FASEB J. 2005;19:1061–1066.
19.
HeX, KanH, CaiL, . Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol. 2009;46:47–58.
20.
ChoHY, ReddySP, KleebergerSR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 2006;8:76–87.
21.
IshiiY, ItohK, MorishimaY, . Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005;175:6968–6975.
22.
vander Toorn M, RezayatD, KauffmanHF, . Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2009;297:L109–L114.
23.
FranckT, KohnenS, de la RebièreG, . Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase. Vet Immunol Immunopathol. 2009;130:243–250.
24.
SarirH, MortazE, JanseWT, . IL-8 production by macrophages is synergistically enhanced when cigarette smoke is combined with TNF-alpha. Biochem Pharmacol. 2010;79:698–705.
25.
TakeyamaK, DabbaghK, JeongSJ, . Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol. 2000;164:1545–1552.
26.
Cervantes-SandovalI, Serrano-LunaJde J, Meza-CervantezP, . Naegleria fowleri induces MUC5AC and pro-inflammatory cytokines in human epithelial cells via ROS production and EGFR activation. Microbiology. 2009;155:3739–3747.
27.
BrownleeIA, KnightJ, DettmarPW, . Action of reactive oxygen species on colonic mucus secretions. Free Radic Biol Med. 2007;43:800–808.
28.
HeX, MaQ. NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation. Mol Pharmacol. 2009;76:1265–1278.
29.
ZhangDD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38:769–789.
30.
ChoHY, JedlickaAE, ReddySP, . Role of Nrf2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol. 2002;26:175–182.
31.
ChoHY, ReddySP, YamamotoM, . The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. 2004;18:1258–1260.
32.
PapaiahgariS, YerrapureddyA, ReddySR, . Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice. Am J Respir Crit Care Med. 2007;176:1222–1235.
RangsamyT, ChoCY, ThimmulappaRK, . Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004;114:1248–1259.
35.
IizukaT, IshiiY, ItohK, . Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells. 2005;10:1113–1125.
36.
SinghA, RangasamyT, ThimmulappaRK, . Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell Mol Biol. 2006;35:639–650.
37.
MaQ, BattelliL, HubbsAF. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am J Pathol. 2006;168:1960–1974.
GrobmyerSR, BariePS, NathanCF, . Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit Care Med. 2000;28:1276–1282.
40.
RoganMP, GeraghtyP, GreeneCM, . Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res. 2006;7:29.
41.
vanWetering S, vander Linden AC, vanSterkenburg MA, . Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol. 2000;278:L51–L58.
42.
KouchiI, YasuokaS, UedaY, . Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases. Tokushima J Exp Med. 1993;40:95–107.
43.
MulliganMS, DesrochersPE, ChinnaiyanAM, . In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2. Proc Natl Acad Sci U S A. 1993;90:11523–11527.
44.
VogelmeierC, HubbardRC, FellsGA, . Anti-neutrophil elasatse defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest. 1991;87:482–488.
45.
LuceyEC, StonePJ, CiccolellaDE, . Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster. J Lab Clin Med. 1990;115:224–232.
46.
RudolphusA, StolkJ, DijkmanJH, . Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am Rev Respir Dis. 1993;147:442–447.
47.
YangJ, ZhuJ, DingA. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Biochim Biophys Acta. 2005;1745:310–317.
48.
Abbinante-NissenJM, SimpsonLG, LeikanfGD. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol. 1993;265:286–292.
49.
SaitohH, MasudaT, ShimuraS, . Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands. Am J Physiol Lung Cell Mol Physiol. 2001;280:L79–L87.
50.
MoreauT, BarangerK, DadéS, . Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor(SLPI), two serine protease inhibitors of the chelonianin family. Biochimie. 2008;90:284–295.
51.
VanWetering S, Vander Linden AC, VanSterkenburg MA, . Regulation of secretory leukocyte proteinase inhibitor(SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. J Invest Med. 2000;48:359–366.
52.
ZhengS, ByrdAS, FisherBM, . Regulation of MUC5AC expression by NAD(P)H:quinine oxidoreductase 1. Free Radic Biol Med. 2007;42:1398–1408.
